We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

SRE Reporter Assay for MAPK ERK Signaling via RTK and GPCR Scientific Poster

SEARCH POSTERS

Abstract

Jey Cheng, Pete Stecha, Keith Wood and Frank Fan
Promega Corporation

Bioluminescent reporter assays are uniquely suited for high- throughput screening due to their inherently high sensitivity, wide dynamic range and low susceptibility to compound interference. Here, we have incorporated the technical advancement of luciferase reporter genes and vectors to build an improved serum response element (SRE) luciferase construct for MAPK/ERK signaling pathway. The large dynamic range of SRE luciferase reporter assay allows efficient screening for RTK inhibitors for receptor tyrosine kinase pathway and also GPCR modulators for GPCR pathway. The Dual-Luciferase Reporter Assay System (Cat.# E1910), wherein the second plasmid expresses the target receptor of interest and Renilla luciferase as internal control, improves data quality by providing simultaneous monitoring of nonspecific effects such as cytotoxicity.

Document Icon Download the poster PDF (184kb)

  • Part# PS086
  • Printed in USA.
Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom